Viral Hepatitis

乙型肝炎是世界上最常见的严重肝脏感染。这个疾病是由于感染了会攻击肝脏细胞的乙型肝炎 病毒(HBV)，还可导致肝硬化(结疤)、肝衰竭或肝癌。在成年时感染这个病毒的大多数健康人都能抵抗感染，清除血液中的病毒。这个过程可能需要 长达 6 个月的时间，而他们在这期间是有传染性的。不幸的是，婴儿和幼年儿童若暴露在 HBV 中，患上慢性(终身)感染的风险非常大。

हेपेटाइटटसबीदनुियामेंसबसेआमऔरसबसेगभं ीरनिगरसक्रं मणह।ै इसकाकारणहोताहैहपे ेटाइनटसबीवायरस(ह.े बी.वी),िोनिगरकीकोनिकाओंपर हमला करता है और इसकी विह से निगर नवफल हो सकता है या नसरोनसस [cirrhosis (scarring)] या निगर में कैं सर हो सकता ह।ै वायरसरक्तकसाथऔररक्तयक्तु िारीररकतरलपदाथथकेसाथसपंकथहोिेकेमाध्यमसेफैलताह।ैऐसाहोताहैप्रत्यक्षनिवेियाअसरुनक्षतयौिसबंधं यागदंीया unsterile सईु के उपयोग से या नफर एक सक्रं नमत मनहला से उसके िविात नििु को उसके िन्म के दौराि।

This document includes fast facts on heaptitis B and how B hepatitis B is the most common serious liver infection in the world. It is caused by the hepatitis B virus (HBV), which attacks liver cells and can lead to cirrhosis (scarring), liver failure, or liver cancer.

 The liver is one of the body’s most important organs. It cleans toxins from the body and helps it digest food and absorb nutrients. The hepatitis B virus lives in the liver and can cause damage. It is important for people with hepatitis to understand their liver and how to protect it.

Liver Cancer Awareness Month Graphics for digital use.

This document discusses how an estimated 2.4 million people in the U.S. are living with hepatitis C infection, while up to 1.59 million people could be living with hepatitis B in the U.S. The need for expanded, standardized, and reliable viral hepatitis surveillance continues to impact public health efforts, resources, and response across the U.S. to this epidemic.

This document discusses how NASTAD strongly encourages 340B program administrators to incorporate health equity into their programs. Health equity means that everyone has a fair and just opportunity to be as healthy as possible and this requires removing obstacles to health such as structural racism and the intentional lack of social safety nets and investments that lead to poverty, unstable housing, food deserts, inadequate infrastructure and environmental injustices. 

This document supports viral hepatitis program administrators in educating and preparing leadership to support 340B program implementation and partnerships. 

The landscape of treatment for hepatitis C virus (HCV) infection has evolved substantially since the introduction of highly effective HCV protease inhibitor therapies in 2011. The pace of change has increased rapidly as numerous new drugs with different mechanisms of action have become available over the past few years.

The recent emergence of the Coronavirus Disease (COVID-19) calls for enhanced cooperation between public health authorities, homeless service systems, and other partners at the local level. HUD strongly encourages CoCs to contact their local public health departments, Healthcare for the Homeless agencies, and other local health partners to ensure the unique needs and opportunities related to the homeless service system are incorporated in plans to prevent and respond to infectious diseases like COVID-19.